Analyst Price Targets — CTEV
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 24, 2026 11:36 am | Stan Berenshteyn | Wells Fargo | $30.00 | $23.23 | TheFly | Claritev price target lowered to $30 from $33 at Wells Fargo |
| February 24, 2026 11:29 am | — | Guggenheim | $38.00 | $23.23 | TheFly | Claritev price target lowered to $38 from $43 at Guggenheim |
| January 8, 2026 9:21 pm | Stan Berenshteyn | Wells Fargo | $33.00 | $31.21 | TheFly | Claritev initiated with an Equal Weight at Wells Fargo |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for CTEV

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will meet with investors at the following investor events in March 2026: Mizuho Virtual Healthcare Technology Conference 2026 – Thursday, March 5, 2026 -…

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, will host its 2026 Investor Day on Monday, March 16, 2026 at the New York Stock Exchange. The event will feature presentations by members of Claritev's management team discussing the company's long term…

SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Claritev Corporation (NYSE: CTEV). The investigation focuses on Claritev's executive officers and whether investor losses may be recovered under federal securities laws.

Claritev Corporation (CTEV) Q4 2025 Earnings Call Prepared Remarks Transcript

Claritev Corporation (CTEV) came out with a quarterly loss of $4.88 per share versus the Zacks Consensus Estimate of a loss of $3.96. This compares to a loss of $5.14 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CTEV.
U.S. House Trading
No House trades found for CTEV.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
